Related Experiment Videos
The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis
Kwok M Ho1, Jeffrey Lipman, Geoffrey J Dobb
1Department of Intensive Care, Royal Perth Hospital, Australia. kwok.ho@health.wa.gov.au
Introduction:
High-risk surgical patients are at increased risk of fungal infections and candidaemia. Evidence from observational and small randomised controlled studies suggests that prophylactic fluconazole may be effective in reducing fungal infection and mortality. We evaluated the effects of prophylactic fluconazole on the incidence of candidaemia and hospital mortality in immunocompetent high-risk surgical patients.
Methods:
Randomised controlled studies involving the use of fluconazole in immunocompetent high-risk surgical patients from the Cochrane Controlled Trial Register (2005, issue 1) and from the EMBASE and MEDLINE databases (1966-30 April 2005), without any language restriction, were included. Two reviewers reviewed the quality of the studies and performed data extraction independently.
Results:
Seven randomised controlled studies with a total of 814 immunocompetent high-risk surgical patients were considered. The use of prophylactic fluconazole was associated with a reduction in the proportion of patients with candidaemia (relative risk [RR] = 0.21, 95% confidence interval [CI] = 0.06-0.72, P = 0.01; I2 = 0%) and fungal infections other than lower urinary tract infection (RR = 0.39, 95% CI = 0.24-0.65, P = 0.0003; I2 = 0%), but was associated with only a trend towards a reduction in hospital mortality (RR = 0.82, 95% CI = 0.62-1.08, P = 0.15; I2 = 7%). The proportion of patients requiring systemic amphotericin B as a rescue therapy for systemic fungal infection was lower after prophylactic use of fluconazole (RR = 0.35, 95% CI = 0.17-0.72, P = 0.004; I2 = 0%). The proportion of patients colonised with or infected with fluconazole-resistant fungi was not significantly different between the fluconazole group and the placebo group (RR = 0.66, 95% CI = 0.22-1.96, P = 0.46; I2 = 0%).
Conclusion:
The use of prophylactic fluconazole in immunocompetent high-risk surgical patients is associated with a reduced incidence of candidaemia but with only a trend towards a reduction in hospital mortality.
Insights
Prophylactic fluconazole significantly reduced candidaemia in high-risk surgical patients. While it showed a trend towards lower hospital mortality, this was not statistically significant.
Area of Science:
- Infectious Diseases
- Surgical Critical Care
- Pharmacology
Background:
- High-risk surgical patients face elevated risks of fungal infections and candidaemia.
- Previous studies suggest prophylactic fluconazole may decrease fungal infections and mortality.
- This study specifically examines immunocompetent patients undergoing surgery.
Purpose of the Study:
- To evaluate the efficacy of prophylactic fluconazole in reducing candidaemia incidence.
- To assess the impact of prophylactic fluconazole on hospital mortality in high-risk surgical patients.
- To analyze the effect on other fungal infections and the need for rescue therapies.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials.
- Inclusion of studies on immunocompetent high-risk surgical patients receiving fluconazole.
- Data extraction and quality assessment performed independently by two reviewers.
Main Results:
- Prophylactic fluconazole reduced candidaemia (RR=0.21) and non-urinary tract fungal infections (RR=0.39).
- A trend towards reduced hospital mortality was observed (RR=0.82), but not statistically significant (P=0.15).
- Reduced need for systemic amphotericin B rescue therapy was noted (RR=0.35).
Conclusions:
- Prophylactic fluconazole effectively lowers the incidence of candidaemia in immunocompetent high-risk surgical patients.
- A trend towards reduced hospital mortality exists, warranting further investigation.
- No significant increase in fluconazole-resistant fungal infections was observed.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Cryptococcal Meningitis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antifungal Agents